Teixeira Cleber E, Priviero Fernanda B M, Webb R Clinton
Department of Physiology, Medical College of Georgia, Augusta, 30912-3000, USA.
J Pharmacol Exp Ther. 2006 Feb;316(2):654-61. doi: 10.1124/jpet.105.092544. Epub 2005 Oct 4.
Presumably, the vasorelaxant properties of phosphodiesterase type 5 (PDE5) inhibitors are similar in isolated blood vessels. We aimed to explore the mechanisms underlying the vasorelaxation induced by the selective PDE5 inhibitors sildenafil, vardenafil, and tadalafil in the rat aorta. Aortic rings were mounted in 5-ml organ baths, and concentration-response curves for PDE5 inhibitors (0.0001-10 microM) were constructed in phenylephrine (PE)-precontracted endothelium-intact and -denuded rings. Cyclic nucleotides were measured using enzyme immunoassay kits. Sildenafil, vardenafil, and tadalafil concentration dependently relaxed aortic rings and increased cGMP, but not cAMP, concentrations. Endothelium denudation caused marked rightward shifts in the curves to sildenafil (45-fold), tadalafil (21-fold), and vardenafil (251-fold). Maximal responses to sildenafil and tadalafil were substantially reduced (38 +/- 1% and 53 +/- 2%, respectively), whereas that evoked by vardenafil was not affected. Likewise, inhibition of NO synthase (N(omega)-nitro-L-arginine methyl ester, 100 microM), guanylyl cyclase (1H-[1,2,4]oxadiazolo [4,3,-a]quinoxalin-1-one, 10 microM), or scavenging of NO ([carboxy-PTIO (2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide), 100 microM]) caused similar attenuation of the vasorelaxations evoked by PDE5 inhibitors. Sildenafil, tadalafil, and vardenafil significantly potentiated relaxations mediated by glyceryl trinitrate (0.0001-3 microM; 8-13-fold) and atrial natriuretic peptide (0.1-100 nM; 2-3-fold). Contractions evoked by CaCl(2) (0.01-5 mM) in PE-treated rings were significantly reduced (26 +/- 4%) by vardenafil, but not sildenafil or tadalafil, whereas phorbol 12,13-dibutyrate-induced contractions were not affected. Ouabain, cyclopiazonic acid, and calyculin A failed to affect vasorelaxations induced by the PDE5 inhibitors. These results suggest that vardenafil, but not sildenafil or tadalafil, affects Ca(2+) handling in the rat aorta in addition to increasing cGMP levels through inhibition of PDE5 to cause relaxation.
据推测,5型磷酸二酯酶(PDE5)抑制剂的血管舒张特性在离体血管中是相似的。我们旨在探究选择性PDE5抑制剂西地那非、伐地那非和他达拉非在大鼠主动脉中诱导血管舒张的潜在机制。将主动脉环安装在5毫升的器官浴槽中,在苯肾上腺素(PE)预收缩的完整内皮和去内皮环中构建PDE5抑制剂(0.0001 - 10微摩尔)的浓度 - 反应曲线。使用酶免疫分析试剂盒测量环核苷酸。西地那非、伐地那非和他达拉非浓度依赖性地舒张主动脉环并增加cGMP浓度,但不增加cAMP浓度。内皮剥脱导致西地那非(45倍)、他达拉非(21倍)和伐地那非(251倍)的曲线显著右移。西地那非和他达拉非的最大反应大幅降低(分别为38±1%和53±2%),而伐地那非引起的最大反应未受影响。同样,抑制一氧化氮合酶(N(ω)-硝基-L-精氨酸甲酯,100微摩尔)、鸟苷酸环化酶(1H-[1,2,4]恶二唑并[4,3,-a]喹喔啉-1-酮,10微摩尔)或清除一氧化氮([羧基-PTIO(2-(4-羧基苯基)-4,4,5,5-四甲基咪唑啉-1-氧基-3-氧化物),100微摩尔])会导致PDE5抑制剂引起的血管舒张类似程度的减弱。西地那非、他达拉非和伐地那非显著增强了由硝酸甘油(0.0001 - 3微摩尔;8 - 13倍)和心房利钠肽(0.1 - 100纳摩尔;2 - 3倍)介导的舒张。在PE处理的环中,CaCl₂(0.01 - 5毫摩尔)引起的收缩被伐地那非显著降低(26±4%),但西地那非或他达拉非未使其降低,而佛波醇12,13 - 二丁酸诱导的收缩不受影响。哇巴因、环匹阿尼酸和花萼海绵诱癌素A未能影响PDE5抑制剂诱导的血管舒张。这些结果表明,伐地那非除了通过抑制PDE5增加cGMP水平以引起舒张外,还影响大鼠主动脉中的Ca²⁺处理,而西地那非和他达拉非则不然。